


Women in Life Science Denmark (WiLD) receives grant from The Lundbeck Foundation to support and advance its Female Leadership Mentoring Program
WiLD is a new and fast-growing professional network for women…

Futura’s Fast-Acting Topical Gel for the Treatment of Erectile Dysfunction Granted Marketing Authorisation by the US FDA for Over the Counter Sale
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a…

Vicore has carried out directed share issuances of in total 29,875,000 shares at a subscription price of SEK 16.75 per share, raising gross proceeds of SEK 500 million
Stockholm, 9 June 2023 – Vicore Pharma Holding AB (publ) (“Vicore”…

Vicore further strengthens patent protection for C21
Stockholm, June 7, 2023 – Vicore Pharma Holding AB (STO:…

Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
NanoBone® technology complements Biocomposites’ absorbable…

Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
Lonza to acquire Synaffix B.V., an innovative biotech company…

iOnctura To Present Research At Leading Scientific Conferences In June 2023
Geneva, Switzerland and Amsterdam, The Netherlands, 1 June 2023 -…

Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics Ltd
Acquisition of next generation radiopharmaceutical clinical…

Zephyrus Innovations appoints David Whitaker as Chief Technology Officer
Vancouver, Canada – 30 May 2023: Zephyrus Innovations (Zephyrus),…

Adcendo ApS Announces Option License Agreement with Duality Biologics to Enhance Optionality to Further Expand First-in-class ADC Pipeline
Strengthening of strategic option license agreement to cover…

Destiny Pharma plc – Dr Debra Barker Appointed Interim CEO
Brighton, United Kingdom – 25th May 2023: Destiny Pharma…

Verona Pharma to Present at Jefferies Healthcare Conference
LONDON and RALEIGH, N.C., May 24, 2023 (GLOBE NEWSWIRE) -- Verona…

InProTher announces EUR 6MSeed financing with the participation of the European Innovation Council Fund to develop first-in-class cancer immunotherapy
• Danish start-up developing immunotherapies designed to fight…

Poolbeg Pharma Plc – Board Appointment
24 May 2023 - Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg'…

Vicore obtains significant new patent protection for C21 in the US
Stockholm, May 23, 2023 – Vicore Pharma Holding AB (STO:VICO)…

Scarlet Therapeutics Announces Seed Financing to Advance Development of Therapeutic Red Blood Cell Platform
Pioneering platform to generate novel therapies with potential…

ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors
Leading medical oncologist and seasoned biotechnology executive…

Engimmune Therapeutics Announces the Appointment of Dr Annalisa D’Andrea to its Board of Directors
Leading industry expert with more than 25 years of experience…

Serca Pharmaceuticals showcases exciting data on 13-M at Heart Failure 2023
First-in-class, cardioprotective drug with potential to transform…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York